PatientsLikeMe was in a haste to find a buyer after regulators at the Committee on Foreign Investment in the U.S. (CFIUS), forced its majority shareholder Shenzhen, China-based iCarbonX to divest their holdings in the startup.
Cambridge, Massachusetts-based PatientsLikeMe is being forced to find a new buyer for the company because of the iCarbonX divesture mandated by U.S. regulators.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.